Navigation Links
Confronting Influenza: Are We Prepared?

"Confronting Influenza: Are We Prepared?" A Symposium Presented by The Howard Hughes Medical Institute and The Center for Strategic and International Studies.

The Howard Hughes Medical Institute (HHMI) and the Center for Strategic and International Studies (CSIS) cordially invite you to attend a symposium on the current state of research, development of prophylactic and therapeutic treatments, and U.S. and global strategies aiming to manage both annual and possible global pandemic influenza outbreaks.

World-renowned speakers will include:

  • Stephen C. Harrison, HHMI Investigator and Professor of Biological Chemistry and Molecular Pharmacology, Professor of Pediatrics and Director of the Harvard-Armenise Center for Structural Biology at Harvard Medical School; and Head of the Laboratory of Molecular Medicine at Children's Hospital, Boston;
  • Dominick A. Iacuzio, Medical Director at Hoffman-La Roche, Inc;
  • Robert A. Lamb, HHMI Investigator and John Evans Professor of Molecular and Cellular Biology at Northwestern University, Evanston, and Professor of Microbiology-Immunology at Northwestern University Medical School;
  • Peter Palese, Chairman and Professor, Department of Microbiology, Mt. Sinai School of Medicine;
  • Timothy M. Uyeki, Medical Epidemiologist, Influenza Branch, Division of Viral and Rickettsial Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention; and
  • Robert G. Webster, Rose Marie Thomas Chair, Division of Virology, St. Jude Children's Research Hospital; Consultant to the World Health Organization (WHO) and the National Institute of Allergy and Infectious Diseases (NIAID); and Director of the U.S. Collaborating Center of the WHO dealing with the ecology of animal influenza viruses.

    Discussion topics will include the structure of the influenza viral proteins and the relevance of that structure for drug development, lessons learned from the 1918 pandemic, current H5N1 (Avia n influenza) developments in Asia, the state of U.S. preparedness and influenza surveillance, and the private sector's views on drug development.


    '"/>


  • Source:Howard Hughes Medical Institute


    Related biology news :

    1. RNA project to create language for scientists worldwide
    2. Disease diagnosis, biodefense among UH chemical research projects
    3. New project aims to make large-scale lobster farms feasible
    4. New Scripps Oceanography project to study sediments and ecosystem restoration in Venice lagoon
    5. ‘Blue Brain?project explores thought at molecular level
    6. Grand Challenges in Global Health initiative funds Yale project
    7. Virtual microscopy project wins educational technology award
    8. St. Jude projects 90 percent cure rate for ALL
    9. UCLA study of community health project shows how group dynamics affect fitness, eating habits
    10. Large-scale genomics project will hunt genes behind common childhood diseases
    11. Ground spider diversity studied in research project
    Post Your Comments:
    *Name:
    *Comment:
    *Email:


    (Date:2/3/2016)... -- --> --> Fourth quarter 2015: ... 1,187% compared with fourth quarter of 2014. Gross margin was ... 30.0). Earnings per share increased to SEK 6.39 (loss: 0.49). ... 74.7). , --> --> ... M (233.6), up 1,142% compared with 2014. Gross margin was ...
    (Date:2/3/2016)... Vigilant Solutions announces today that the ... Missouri solved two recent hit-and-run cases with ... Vigilant Solutions. Brian Wenberg explains, "I ... was walking out of a convenience store and witnessed an elderly male back ... striking his vehicle and leaving the scene.  In his ...
    (Date:2/2/2016)... 2016  BioMEMS devices deployed in hospitals ... medical screening and diagnostic applications, such as ... that facilitate and assure continuous monitoring without ... being bolstered through new opportunities offered by ... coupled with wireless connectivity and low power ...
    Breaking Biology News(10 mins):
    (Date:2/11/2016)...  Vermillion, Inc. (NASDAQ: VRML ), a bio-analytical ... formation of the Steering Committee for its Pelvic Mass ... Pelvic masses can present physicians and healthcare professionals ... is ruled out, pelvic masses may include cancers of ... ovarian tumors and gastrointestinal and urinary tract masses. ...
    (Date:2/11/2016)... Feb. 11, 2016  Wellcentive today announced it ... Portland, Oregon -based community care organization (CCO) ... health analytics, quality reporting and care management solutions ... its team of quality managers, analysts and care ... provider groups serving FamilyCare members. ...
    (Date:2/11/2016)... 11, 2016   BioInformant announces the February ... Research Products, Opportunities, Tools, and Technologies – Market Size, ... The first and ... cell industry, BioInformant has more than a decade of ... market, by stem cell type. This powerful 175 page ...
    (Date:2/10/2016)... 2016 /PRNewswire/ - BioAmber Inc. (NYSE: BIOA ), ... that Mitsui & Co. Ltd., its partner in the ... is investing an additional CDN$25 million in the joint ... from 30% to 40%.  Mitsui will also play a ... in Sarnia , providing dedicated resources ...
    Breaking Biology Technology: